Fig. 5. Actuarial risk of relapse after... | American Society of Hematology

$Fig. 5. Actuarial risk of relapse after allogeneic BMT for patients with refractory anemia ± ringed sideroblasts (RA/RARS; n = 14) and all other diagnoses (n = 46).$

Fig. 5.

Actuarial risk of relapse after allogeneic BMT for patients with refractory anemia ± ringed sideroblasts (RA/RARS; n = 14) and all other diagnoses (n = 46).

This Feature Is Available To Subscribers Only